Browsing Tag
Bristol Myers Squibb Company
2 posts
Can Bristol Myers Squibb turn Claude into pharma’s first enterprise AI operating layer?
Bristol Myers Squibb is moving Claude beyond chatbots. The bigger test is whether agentic AI can change how pharma actually works.
Atrium Therapeutics (Nasdaq: RNA) Q1 results show cash runway and clinical urgency behind precision cardiology bet
Atrium has cash and RNA ambition. The harder test is whether heart-targeted delivery can turn rare cardiomyopathy science into clinical proof.